Friend disease in vitro by unknown
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The polycythemia- and anemia-inducing strains (1, 2) of Friend murine erythroleu- 
kemia  virus  (FLV-P and  FLV-A,  respectively)  1 have been  the  subject  of intensive 
studies for several years. Virus preparations contain a mixture of  a helper-independent 
virus (F-MuLV) and a replication-defective spleen focus-forming virus (SFFV; 3, 4). 
At one level, attention has been focused upon the biology of the disease  (5, 6);  the 
nature and molecular biology of the helper-independent (F-MuLV) and replication- 
defective (SFFVA and SFFVp) transforming viruses (7-10); the target cells and genetic 
restriction for replication and transformation  (6,  11-15);  and  the response of these 
cells to the hormone erythropoietin (16,  17). At a  second level, cell lines have been 
established  from the  leukemic tissue of viral-infected mice (18,  19)  and  these lines 
have been very useful in analyzing the molecular events associated with hemoglobin 
production after treatment with a variety of inducing agents (20). 
However, the relationship between the Friend tumor cell lines and the polycythemia 
or anemia seen after in vivo infection with SFFVp (F-MuLV) or SFFVA (F-MuLV) 
is still uncertain. For example, shortly after infection of susceptible mice with these 
viral complexes, marked alterations are seen in the levels of myeloid progenitor cells 
occurring concomitantly with an increased sensitivity (maybe true independence) of 
the erythroid progenitor cells to erythropoietin (6, 21). This is followed in the terminal 
stages of the disease by the emergence of transplantable, malignant cells (6, 22, 23). 
Whether  these  two  phases  represent  a  manifestation  of infection and  consecutive 
development of different cell populations, or merely reflect the sequential expression 
of transformation in the same cell population, has not been determined. 
An in vitro system that reproduced all aspects of Friend disease would have obvious 
advantages in the analysis of the role of the respective viruses and the molecular and 
cell-biological events following viral infection. Short-term in vitro cultures have had 
some success in determining the developmental stage at which the erythroid progenitor 
cells become susceptible  to  SFFVA or  SFFV1,  in  terms of their ability  to  undergo 
clonal expansion and  maturation  in  the  absence of detectable erythropoietin; and 
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using  such  assays,  differences  have  been  detected  in  the  capacity of pseudotyped 
SFFVA and SFFVp virus-infected cells  to undergo hemoglobinization in the absence 
of erythropoietin (17).  In another system, after infection of hemopoietic cells  in vitro 
with  FLV-P, cell  lines  have been  established  that  have characteristics  in  common 
with Friend tumor cell lines derived from in vivo infections (24).  So far, however, no 
in vitro system has been described that faithfully duplicates Friend disease. 
In this respect, long-term bone marrow cultures would appear to offer a  suitable 
model system. In these cultures, hemopoietic stem cell proliferation and self-renewal 
can  occur  for  several  months  (25) but  only  in  the  presence  of  an  appropriate 
population of marrow-derived adherent cells that provide the inductive environment 
necessary  for  hemopoiesis  to  occur  (26).  Differentiation  of stem  cells  leads  to  the 
continual production of progenitor cells of the different myeloid lineages: the granu- 
locyte-macrophage colony-forming cells  (GM-CFC), megakaryocyte colony-forming 
cells  (Meg-CFC),  and  erythroid  burst-forming  units  (BFU-E;  25-28).  However, 
whereas the GM-CFC and Meg-CFC subsequently undergo maturation to produce 
mature granulocytes, macrophages, and megakaryocytes, the majority of BFU-E in 
these cultures are normally "blocked" at the most primitive level of development (28). 
However, addition of either erythropoietin in combination with mechanical agitation 
(28) or treatment with anemic mouse serum  (29) leads to sequential development of 
the BFU-E to produce progressively more mature progeny (day 4 BFU-E and day 2 
erythroid  colony-forming units  [CFU-E])  leading  ultimately  to  the  production  of 
mature non-nucleated erythrocytes. This ability to induce erythropoiesis in a more or 
less  synchronous fashion  offered exciting  possibilities  in  the  viral  erythroleukemia 
systems. In this communication we present data on the results of SFFVp (F-MuLV) 
infection  and  show  that  all  aspects  of the  SFFV~,  (F-MuLV)  disease  can  now  be 
reproduced in vitro. 
Materials and Methods 
Long-Term Cultures.  These were established  as previously described  (25) with some modifi- 
cations (28). The cellular contents of single femora from 12-wk-old, virgin DBA/2 female mice, 
were flushed into screw-capped Falcon TC flasks (25-cm  ~ growing area;  Falcon Labware,  Div. 
of Becton, Dickinson  & Co., Oxnard, Calif.) containing 10 ml of Fischers'  medium  (Grand 
Island  Biological Co.,  Grand  Island,  N.  Y.)  sup6plemented with  20%  horse  serum  (Flow 
Laboratories, Hamden, Conn.), antibiotics, and 10-  M hydrocortisone sodium succinate. After 
gassing with 5% CO2 in air, the screw-caps were tightly closed, and the cultures were incubated 
at 33°C. The cultures were fed weekly by the removal of half (5 ml) of the growth medium and 
the addition of an equal volume of fresh medium.  In these cultures,  residual  erythropoiesis 
disappears within  1-2 wk (28). 
After 2 wk growth, when many primitive  but few late  erythroid progenitors  were present, 
(28) the cultures were demi-depopulated  and fed with alpha medium supplemented  with (final 
concentrations)  400 #g/ml transferrin;  10  -4 M 2-mercaptoethanol;  15% horse serum; 5% fetal 
calf serum  (Sera  Labs,  Crawley  Down,  England);  10  -s M  hydrocortisone  sodium  succinate 
(Sigma Chemical  Co., St. Louis, Mo.), and antibiotics.  The cultures were gassed as before and 
transferred  to 37°C (29). Some cultures were further  supplemented  with anemic mouse serum 
(AMS) at a final concentration of 5% vol:vol. All cultures were subsequently demi-depopulated 
and re-fed at weekly intervals with growth medium containing the required supplements. AMS 
addition  was maintained only for three weekly consecutive feedings. 
We  have  found  that  using  this  protocol,  AMS  will consistently  induce  high  levels of 
erythropoiesis in the long-term  cultures.  Either  four or five cultures were established  for each 
experimental  group and the results represent  the data from pooled cell suspensions of these 
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For morphological analysis, smear preparations were stained with benzidine, followed by 
May-Grunwald-Giemsa. 
AMS.  AMS was used as the erythropoietic stimulus to  the  long-term cultures and  was 
prepared  as  previously described  (29,  30).  The  batch  of AMS  used  contained  10  U/ml 
erythropoietin when assayed in hypertranfused mice. 
Hemopoietic Progenitor Cell Assays.  The cells present in the growth medium removed during 
feeding were counted directly on a hemacytometer. After centrifugation, the cells were resus- 
pended in Fischers' medium at an  appropriate dilution, counted again, and assayed for the 
presence of hemopoietic stem cells (CFU-S), GM-CFC, BFU-E, and CFU-E progenitor cells 
(25, 28). 
Medium conditioned by the growth of WEHI-3 myelomonocytic leukemia cells was used as 
a  source of GM  colony-stimulating factor  (CSF)  and  104-105 cells were  plated  in  1 ml  of 
Fischers' medium supplemented with 20% horse serum and 0.3% agar in 35-mm plastic Petri 
dishes (Sterilin, Teddington, England). For GM-CFC assays, triplicate plates were established 
in the presence and the absence of GM-CSF. Colonies were scored after 7 d at a magnification 
of 25.  Note that  in virus-treated cultures, there was a  sequential development of GM-CSF- 
independent colonies. Cells producing these colonies have been termed agar CFC. 
CFU-S were assayed by the method of Till and McCulloch (31).  104-105 cells (occasionally 
more) were injected intravenously into groups of at least five syngeneic mice that had received 
8  Gy (a few hours  previously) from a  linear accelerator producing  12  meV,  dose rate  1.67 
Gy/s. This dose of radiation was sufficient to ablate endogenous hemopoiesis. 
Assays for BFU-E and CFU-E have been described in detail elsewhere (28, 29). For BFU-E 
assays,  the  culture  medium  was  supplemented  with  2  U/ml  erythropoietin  (Connaught 
Laboratories, Ontario, Canada; step III) and  106 irradiated bone marrow cells as a source of 
burst-forming activity (32).  In CFU-E assays, 0.5 U/ml of erythropoietin was added before 
plating. BFU-E were scored on day 10 and CFU-E were scored on day 2. At least two plates 
were established per point, in the presence and in the absence of erythropoietin. 
Virus Treatment and Assays.  2 wk after the last treatment with AMS, the cultures were demi- 
depopulated and fed with fresh medium. 24 h later, 0.5 ml of SFFVp (F-MuLV) was added to 
the AMS-induced and control (noninduced) cultures. This SFFVp (F-MuLV) virus complex 
(hereafter called FLV-P) was obtained by superinfeetion of SFFVp-infeeted 3T3 nonproducer 
cells (33) with clone 57 of F-MuLV (7). This preparation had an activity of 5 ×  105XC plaque- 
forming units/ml and  2  ×  104  focus-forming units/ml when  measured by the spleen focus- 
forming assay (4). 
Electron Microscopy.  Cell  pellets  or  whole  cultures  were  fixed  in  3%  glutaraldehyde  in 
Sorenson's phosphate buffer, pH  7.3,  for 30 min, followed by three buffer washes and post- 
fixation in 1% OsO4 in the same buffer for 30 min. After ethanol dehydration, the pellets were 
infiltrated and embedded using hydroxypropylmethacrylate and Lufts Epon (Taab Laborato- 
ries, Reading, England). After sectioning and staining with uranyl acetate and lead citrate, the 
sections were examined in an AE1  EMS01A electron microscope (Kratos Ltd., Manchester, 
England).  For scanning electron microscopy, whole cultures were  fixed and  dehydrated as 
above,  critical point  dried  from  CO2,  sputter-coated with  200  nm  gold,  and  viewed  in  a 
Cambridge $4-10 scanning electron microscope (Cambridge Instrument Co.,  Inc., Ossining, 
N. Y.) at an accelerating voltage of 20 kV. 
Results 
Effects ofFL V-P in Non-AMS-induced Cultures.  The results are shown in Tables I and 
II. In control cultures, not treated with AMS or FLV-P, cell proliferation occurred for 
28 wk. During the first 20 wk, the majority of cells produced consisted of granulocytes 
(all maturation stages), but macrophages subsequently predominated. No morpholog- 
ically recognizable erythroid cells were produced throughout  this period of culture. 
CFU-S were  maintained  for  at  least  14  wk,  then  declined;  GM-CFC  were  present 
(albeit at reducing levels) until the cultures were terminated. At 6 and 7 wk, significant 
numbers of BFU-E were present that were absolutely dependent upon the presence of T.  M.  DEXTER,  T.  D.  ALLEN,  N.  G.  TESTA,  AND  E.  SCOLNICK 
TABLE  I 
Effect of FL V-P Infection on Total Cellularity and Morphology in Long-Term 
Marrow Cultures * 
Total  Weeks 
Group  cultured  cells  U  EG  LG  M4~  EBL  BZN  EC 
<x Io~ 
Control  6  29.0  3  18  78  0  0  0  0 
Control  7  72.0  12  15  70  0  0  0  0 
FLV-P  7 (1)  53.0  14  10  75  0  <1  <1  0 
Control  10  43.1  22  9  67  1  0  0  0 
FLV-P  10 (4)  37.2  19  12  60  1  6  3  ++ 
Control  14  28.2  3  1  85  9  0  0  0 
FLV-P  14 (8)  19.8  2  t2  71  10  2  2  1 
Control  18  27.1  40  6  52  2  0  0  0 
FLV-P  18 (12)  22.2  36  14  36  4  1  0  0 
Control  28  l 4.1  3  1  8  88  0  0  0 
FLV-PP  28 (22)  9.8  6  13  9  71  1  0  0 
* U, undifferentiated cells; EG, early granulocytes (promyelocytes  and mye- 
locytes);  LG,  late  granulocytes  (metamyelocytes  and  polymorphonuclear 
cells); M4~, macrophages; EBL,  erythroblasts; BZN, benzidine-positive nu- 
cleated cells; EC, mature, nonnucleated erythrocytes.  Cultures were termi- 
nated after 28 wk.  Numbers in parenthesis represent weeks cultured after 
FLV-P infection.  ++, clumps of mature erythroeytes 
TABLE  II 
Effects of FL V-P Infection on Progenitor Cell Production in Long-Term Marrow 
Cultures 
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Weeks 
Group  cultured  CFU-S* 
GM-CFC*  BFU-E*  CFU-E* 
+  -  +  -  +  - 
Control  6  ND~  13,141  0  1,740  0  10  0 
Control  7  730  4,795  0  678  0  70  0 
FLV-P  7 (1)  410  6,570  0  662  0  23,685 13,912 
Control  t0  300  2,040  0  ND  ND  ND  ND 
FLV-P  10 (4)  175  2,951  0  ND  ND  ND  ND 
Control  14  205  790  0  ND  ND  ND  ND 
FLV-P  14 (8)  177  872  0  ND  ND  ND  ND 
Control  18  0  580  0  0  0  0  0 
FLV-P  18 (12)  54  1,509  0  0  0  0  0 
Control  28  ND  100  0  0  0  0  0 
FLV-P  28 (22)  ND  750  0  0  0  0  0 
* Total  number present in the nonadherent cells of the long-term cultures on  the 
weeks indicated. GM-CFC plated with (+)  or without (-) GM-CSF. BFU-E and 
CFU-E plated with (+)  and without (-) erythropoietin. Numbers in parentheses 
represent weeks cultured after FLV-P infection. 
:~ Not determined. 
erythropoietin for their development. Only low levels of CFU-E  were present, a  result 
agreeing with our previous observations (28, 29). 
In FLV-P-infected cultures, a  comparable level of overall cell production was seen. 
However, although the majority of cells produced consisted of maturing  granulocytes, 
we found that, in contrast to the controls, a  low level of erythropoiesis was seen  1-8 
wk after infection (Table I).  All stages of erythroid maturation  were seen from the 598  FRIEND  DISEASE  IN  VITRO 
proerythroblast through to the mature, enucleated erythrocytes; but the number of 
erythroid cells produced rarely exceeded 10% of the total cells harvested. In terms of 
progenitor cell production (Table II), we found that CFU-S and GM-CFC production 
was equivalent to that seen in control cultures. At no stage was agar colony growth 
seen that was independent of added GM-CSF. Of considerable interest is that  1 wk 
after infection, BFU-E numbers were also equivalent to control levels (and showed a 
similar erythropoietin dependency), but large numbers of CFU-E were also present. 
Moreover, CFU-E  colony development in  the  absence of exogenous erythropoietin 
was  50%  that  seen in the presence of erythropoietin, i.e., late erythroid progenitors 
that  grew independently of added erythropoietin had  been generated as a  result of 
FLV-P infection. 
Subsequently,  there  was  a  gradual  conversion  of  the  cultures  to  macrophage 
production, erythropoiesis was terminated, and the cultures were discarded. 
Effects of FL V-P in AMS-induced  Cultures.  Nonadherent  cell production in  AMS- 
treated  cultures  with  or  without  FLV-P  infection  is  shown  in  Fig.  1,  and  the 
morphology of the cultured cells is shown  in  Fig.  2.  In  AMS-treated cultures, cell 
production was maintained for 14 wk, but subsequently declined. The three consec- 
utive weekly treatments with AMS induced a progression of the normal granulocytic 
nature of the cultures (Fig. 3a and d) into a fairly well-defined peak of erythropoiesis, 
commencing 10-14 d after the first treatment and declining within 28 d after the last 
treatment (Figs.  2 and 3b, f, and g). These results are in agreement with our previous 
findings  (29).  It is worth noting that  the earliest morphologically recognizable cells 
(erythroblasts)  are  out  of phase  with  xhe  later  cells,  which  indicates  sequential 
development. 
In cultures treated with AMS and FLV-P, cell production was maintained in excess 
of  44 wk (Fig. 1), and during this time granulocytic production declined concomitantly 
with a  massive  increase in  the production of erythroblasts  (Figs.  2  and  3c and  e). 
Furthermore, hemoglobinized, nucleated erythrocytes were being produced through- 
out this period at levels varying from 1 to 10% of total cell production. The major site 
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Fro.  1.  Production of nonadherent cells in AMS-induced cultures treated with FLV-P. Cultures 
were  treated  as  indicated  with  AMS  and  FLV-P,  and were  demi-depopulated weekly.  Symbols 
represent the number of cells present in the growth medium at the time of feeding (O), AMS alone; 
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Ftc.  2.  Morphological analysis of nonadherent cells in AMS-induced and FLV-P-treated cultures. 
Cultures were treated as indicated with AMS and FLV-P. Open symbols represent cultures treated 
with AMS alone. Closed symbols represent cultures also treated with FLV-P. (/X, A), granulocytes; 
(I-I, m), erythroblasts;  (O, O), hemoglobinized cells. The results are expressed as the total number 
of cells present in the growth medium at the time of feeding. 
of production of these erythroid elements appeared  to be  the adherent cell  layer, 
which was heavily infiltrated with primitive erythroid cells. 
Analysis of hemopoietic progenitor cell  populations showed that in the control, 
AMS-treated cultures, CFU-S and GM-CFC production was maintained for 14 wk 
Table III). In these cultures (unlike non-AMS-treated cultures), there was a significant 
production of CFU-E throughout the period of AMS-induced erythropoiesis.  Growth 
of the majority of these CFU-E was dependent upon added erythropoietin; <10% 
control level CFU-E formation occurred in the absence of erythropoietin. 
In  FLV-P-treated cultures,  CFU-S  and  GM-CFC  were  maintained for  11  wk, 
during which time the progenitor cells were apparently normal: producing spleen 
colonies containing all the myeloid lineages  (erythroid, granulocytic, and megakary- 
ocytic), and  agar  colonies  containing granulocytes and  macrophages.  1 wk  after 
infection with FLV-P, erythropoietin-dependent BFU-E were present. CFU-E were 
also  being produced, but  it  is  of considerable interest  that  ~50%  of these  would 
produce colonies in the absence of added erythropoietin (compare this with control 
cultures in which <10% erythropoietin-independent CFU-E were present). After 14 
wk (8 wk after infection) "normal" clonogenic hemopoietic progenitor cells could not 
be  detected  in  our  assay systems  and  the  morphology of the  cultures  showed  a 
dominance of primitive erythroid cells. Injection of these cells into potentially lethally 
irradiated  mice produced spleen  colonies  containing only erythroid cells--mainly 
erythroblasts, although some maturing ceils were present.  Furthermore, by 8 wk after 
infection, large numbers of undifferentiated clonogenic cells were present. These cells 
would readily clone in soft  agar or in methocel in the absence  of the appropriate 
stimulating factors required for normal GM-CFC, BFU-E, or CFU-E development. 
Morphological analysis of these colonies showed them to consist of undifferentiated 
cells. Occasional hemoglobinized cells were present.  When examined individually, all 600  FRIEND  DISEASE  IN  VITRO 
FIG.  3.  Light and electron  microscopic analysis of control cultures, AMS-induced cultures, and 
AMS-induced cultures treated with FLV°P. (a) Appearance ofnonadherent cells before the addition 
of AMS.  All  stages of granulopoiesis are  present,  including  fully  mature  neutrophils.  ×  1,000. 
(b) Appearance of cultures at the time of maximal erythropoiesis induced by AMS. This prepara- 
tion  shows an aggregate of mature erythrocytes with a  few  normoblasts.  Such aggregation corn- T.  M.  DEXTER,  T.  D.  ALLEN,  N.  G. TESTA, AND E.  SCOLNICK  601 
cultures in the groups documented above showed a similar progression, and the events 
described are not unique events occurring in occasional cultures. 
Leukemia and Virus Assays.  To check for the production of SFFV, cell-free supernates 
obtained  from  AMS-induced cultures  2,  14,  and  28  wk after FLV-P  infection, and 
from non-AMS-treated cultures 2 and  14 wk after FLV-P treatment, were injected at 
limiting dilutions into normal adult DBA/2 mice. The mice were killed 8 d  later and 
the number of spleen foci were enumerated. On these occasions, between 3 ×  103 and 
3  ×  104  focus-forming units/ml  were  present  in the supernates.  Control  supernates 
yielded no spleen foci. Also, no significant differences were seen in the titers of SFFV 
recovered from noninduced and AMS-induced cultures treated with FLV-P. 
Both  the  cells and  the  cell-free supernates  derived  from  FLV-P-treated  cultures 
would  produce  leukemia  in  nonirradiated adult  DBA/2  mice.  Gross  splenomegaly 
was observed between  14 and  30  d  after intravenous  infection and  morbid animals 
had hematocrits between 62  and  71, i.e., the polycythemia-inducing capacity of the 
original virus had been maintained in the long-term-cultured cells. 
Production of Cell Lines from  FLV-P-treated  Cultures.  At  2,  10,  20,  and  40  wk after 
FLV-P treatment  of AMS-induced cultures, we attempted to subculture the nonad- 
herent  cells in  fresh  culture  flasks. Various  growth  conditions were  used:  Fischers', 
McCoy's, or alpha  media supplemented with  various concentrations  of horse  sera, 
fetal calf serum, with or without  transferrin and hydrocortisone, and cultured at 33 
or 37°C.  In these circumstances, cell lines that  grew independently of the adherent 
layer of the primary culture could not be established. After an initial growth, the cells 
died. 
However, at 20 and 30 wk after infection, we transferred the floating cells from the 
FLV-P-infected cultures onto normal, noninfected bone marrow-derived adherent cell 
layers from  DBA/2  mice. These  adherent  cells had been  established in the conven- 
tional way as for long-term  marrow  cultures and  had  been  grown  for 3  wk  in  20% 
horse  serum  supplemented  with  10  -6  M  hydrocortisone  before  inoculation  of the 
FLV-P-infected ceils. To ablate endogenous hemopoiesis, occurring within the adher- 
ent cell layer, the cultures were irradiated (with 10 Gy from a Cs source) immediately 
before use. After irradiation, all the growth medium was removed and replaced with 
10 ml of fresh medium  (alpha medium supplemented with  15% horse serum and 5% 
fetal  calf serum)  containing  ~10  ~  pooled  cells  from  the  FLV-P-treated  cultures. 
Within  a  few  days,  the  irradiated  adherent  layer was  seen  to  be  infiltrated  with 
primitive erythroid cells and extensive proliferation was obviously occurring. These 
cultures have now been maintained for 25 and  15 wk, respectively, and in all respects 
are similar to the original cultures from which the FLV-P-infected cells were derived, 
monly occurs around a central  macrophage  (29). ×  1,000. (c) Nonadherent  cells harvested  from 
cultures 20 wk after AMS induction and treatment with FLV-P. Note the hyperbasophilic  nature 
and homogenous appearance of these cells. × 1,000. (d) TEM section through pellet of cells from a 
granulopoietic  culture before  addition of AMS.  Several stages of granulocyte  maturation  are 
apparent. PM,  promyelocytes, MM,  metamyelocytes; N,  mature neutrophil.  × 4,575. (e)  TEM 
section through pellet of cells from cultures 20 wk after AMS induction and treatment with FLV-P. 
Both  nuclear  and  cytoplasmic  morphology  are  undifferentiated,  indicating a  relatively  early 
erythroid type cell. (t) TEM section through in situ-prepared-AMS-induced erythrocytic culture. P, 
proerythroblasts;  B, basophilic erythroblast;  Po, polychromatophilic  erythoblasts;  and N, normo- 
blasts, indicate the stages of erythrocyte maturation. × 4,000. (g) SEM preparation of erythrocytic 
culture, showing stages in the maturation of reticulocytes (R) grouped on a central macrophage (M) 
into typical erythrocytes (E). × 5,000. 602  FRIEND  DISEASE  IN VITRO 
TABLE III 
Effects of FL V-P Infection on Progenitor Cell Production in AMS-induced Long-Term Marrow Cultures 
Weeks 
Group  cultured  CFU-S 
Agar CFC*  BFU-E*  CFU-E* 
+  --  +  --  +  -- 
AMS  6  180  3,016:~  0  160  0  7,016  680 
AMS  8  218  4,0801:  0  83  0  9,661  677 
AMS +  FLV-P  8 (2)  270  1,280:l:  0  78  0  5,804  2,667 
AMS  14  70  680~  0  ND  I  ND  ND  ND 
AMS +  FLV-P  14 (8)  10a§  10a§  10a§  ND  ND  ND  ND 
AMS +  FLV-P  20 (14)  2 ×  lOa§  2 ×  103§  2 x  10a§  2 ×  10a§  2 ×  lOa§  SC¶  SC 
AMS+FLV-P  24 (18)  4X lOa§  4×  lOa§  4×  10a§  4× 10a§  4×  10a§  SC  SC 
AMS+FLV-P  44 (38)  6X 10a§  8X 10a§  4X  10a§  4X  10a§  6×  10a§  SC  SC 
* All results are expressed as number of colonies/106 cells. Agar CFC were plated with (+) or without (-) 
GM-CSF. BFU-E and CFU-E were plated with (+) or without (-) erythropoietin. 
Normal colonies of granulocytes  and macrophages.  Control AMS-treated cultures were discarded  after 
20 wk. Numbers in parenthesis  (week cultured) represent number of weeks after FLV-P infection). 
§ Colonies of undifferentiated erythroblasts  with occasional hemoglobinized cells. 
l[ Not determined. 
¶ Small clusters of undifferentiated cells. 
TABLE  IV 
Karyotype of Cell Lines Derived  from FL V-P-infected Cultures 
Chromosome  number 
38+1  38+2  39+1  40+1  Cell line  (centromeres)*  Polyploid  mc~  me  mc  me 
38  39  40  41  42 
% 
AV-1  0  21  28  2  0  15  2  1  15  16 
AV-2  1  1  80  1  1  13  0  0  0  3 
* 100 metaphases  were scored  for each  cell line. Chromosome  analysis was performed  as 
previously described  (35, 36). 
:]: Metacentric chromosomes. 
i.e., they are producing SFFV;  they show proliferation of erythroblasts with produc- 
tion of 1-5% hemoglobinized cells;  and cells can be cloned in soft  gels and produce 
spleen colonies in mice. 
Of  major  interest  is  that  from  these  secondary  cultures,  permanently  growing 
autonomous  cell  lines could  readily be  estabished,  i.e.,  when  the  nonadherent  cells 
were  removed  from  the  secondary  cultures  (even  after  only  2  wk.)  and  diluted  in 
growth medium, proliferation occurred and the cells could be routinely subcultured. 
This  growth  occurred  autonomously  of  added  regulators  such  as  erythropoietin. 
Furthermore,  these  cells  have  become  completely  independent  for  growth  on  the 
marrow-adherent  cells. Of four such cell lines so  far examined, the majority of cells 
consist of primitive erythroid cells (similar to those shown in Fig. 3c and e), show low 
levels of spontaneous hemoglobinization  (1-5%  of cells),  and  can  be  cloned  in  soft 
agar with a  plating efficiency of 10-35% and show a  population doubling time of 12- 
18 h.  Karyotype analysis of two cell lines is shown in Table IV.  Both cell lines show 
the  development  of aneuploidy.  Of some  interest  is  that  the  addition  of dimethyl 
sulfoxide at final concentration of 1.5, 2, 3, or 4% did not lead to enhanced production 
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Discussion 
In the erythroid lineage, a complex series of events occurs after FLV-P infection in 
vivo,  including  an  increase  in  the  number  of hyperbasophilic erythroid cells,  the 
production of erythropoietin-independent erythroid progenitor cells, and a  marked 
polycythemia leading ultimately to the generation of Friend tumor cells, which are 
able  to grow autonomously in  vitro and  "spontaneously" produce hemoglobinized 
cells (6). We have now shown that all these aspects of Friend disease can be reproduced 
in vitro. 
The experimental data are best  considered in  two parts:  (a)  FLV-P infection of 
normal  long-term  cultures,  and  (b)  FLV-P  infection  of AMS-induced  erythroid 
cultures. 
(a)  In the first case, we have consistently found that in the conditions used, FLV-P 
regularly  induces  the  production  of low  but  significant  levels of morphologically 
recognizable erythroid cells as well as the production (1 wk after infection) of a large 
number of CFU-E (at least 50% of which will grow independently of added erythro- 
poietin). However, hemoglobinized cells are present only for 8-9 wk after infection, 
and erythroid progenitor cells cannot be detected by 12 wk after infection. Because 
long-term cultures normally contain relatively high levels of  primitive BFU-E (forming 
colonies after 10 or  14 d  incubation), and progressively fewer late BFU-E  (forming 
colonies after 4 or 7 d incubation) and CFU-E (28, 29), it is not possible to determine 
whether the massive increase in CFU-E observed 7 d after FLV-P infection is due to 
a  feed-in  from  the  early  BFU-E  compartment,  and/or  amplification  from a  later 
progenitor cell (the day 4 BFU-E or the CFU-E). Nonetheless, infection with FLV-P 
is  certainly  having  a  greater  effect on  the  generation  of CFU-E  rather  than  the 
primitive BFU-E, which are retained at control levels. Furthermore, the erythropoi- 
etin-independent production of mature erythrocytes in the long-term cultures, and in 
methocel,  suggests  that  the  sensitivity  of the  CFU-E  to  this  hormone  has  been 
markedly altered. This agrees with the effects of FLV-P observed by others (16,  17). 
However, the major feature to emerge from this work is that although FLV-P infection 
generated CFU-E formation and erythropoietin-independent erythropoiesis, this was 
not sufficient by itself to give a sustained erythropoiesis or to lead to the production 
of tumor cell lines. 
Another point  is  worthy of comment:  infection of noninduced or AMS-induced 
cultures with FLV-P does not lead to a marked increase in the CFU-S or committed 
granulocyte progenitor cells, the GM-CFC. This contrasts with the effects of FLV-P 
in  vivo  (34)  and  is  in  direct contrast  to  our earlier  in  vitro studies,  using  Friend 
erythroleukemia virus  (35), where marked  increases in  CFU-S  and  GM-CFC  were 
seen.  However, in these earlier studies, the virus preparations had  not been cloned 
and the growth conditions in vitro were different from those described herein, i.e., the 
growth medium used did not facilitate erythropoiesis. Consequently, it is difficult to 
ascribe the effects observed in our previous cultures to FLV-P. The increase in the 
numbers  and  maintenance  of  CFU-S  and  GM-CFC  (35)  may  have  been  only 
indirectly related  to  viral  infection  (a  leukemoid reaction?)  and  the  generation of 
permanently growing cell lines (36) may be related to infection with the Friend helper 
component, the F-MuLV. However, recent work by Greenberger et al. (37), who also 
found that FLV-P infection of long-term marrow cultures had a marked effect upon 
granulopoiesis  and  GM-CFC  production,  suggests  that  the  SFFVp  may  also  be 604  FRIEND DISEASE IN VITRO 
implicated in the generation of "promyelocytic" leukemia cell lines. Nonetheless, the 
data  presented  here clearly show  that  infection with  cloned  FLV-P  per  se  is  not 
sufficient  to  induce  hyperplasia  of the  stem  cell  or  granulocytic  progenitor  cell 
compartments  in  circumstances  where  one  of the  biological  activities  of FLV-P 
infection (erythropoietin-independent erythropoiesis) is induced.  In other words, in 
non-AMS-induced  FLV-P-infected cultures,  the  multiparametric  nature  of Friend 
disease in vivo has been restricted to only one cell lineage. 
(b)  Infection of AMS-induced  (erythroid) cultures with FLV-P gives a  biological 
response consistent with the effects observed in vivo, i.e., erythropoietin-independent 
erythropoiesis occurring concomitantly with a massive production of primitive eryth- 
roid cells. Unlike non-AMS-induced cultures, this erythroid hyperplasia is maintained 
for a prolonged period without the necessity of further addition of an erythropoietic 
stimulus (AMS). This raises several intriguing questions. 
First, by what mechanism are these erythroid cells being generated? The simplest 
explanation would be to assume that  the late erythroid cells are continually being 
generated from the BFU-E, a progression that is mediated by FLV-P infection. This 
seems unlikely, however, because a  sustained  erythropoiesis does not occur in non- 
AMS-induced  cultures  that  are  productively  infected  with  FLV-P  and  where  a 
transient erythropoietin independent erythropoiesis is seen. Therefore, a  more likely 
explanation is that relatively late (post-BFU-E) erythroid cells are undergoing exten- 
sive amplification and/or self renewal as a result of FLV-P infection. If so, the obvious 
difference  between  noninduced  and  AMS-induced  cultures  would  be  the  initial 
number of target cells that were present at the time of viral inoculation. Noninduced 
cultures show only low levels of CFU-E. On the other hand, AMS-induced cultures, 
at the time of virus treatment, were undergoing extensive erythropoiesis and showed 
significant production of the whole range of clonogenic progenitor cells (from the day 
I0 BFU-E to the day 2 CFU-E). In this respect, it is significant that the target cells for 
erythropoietin-independent "bursts," seen after in vitro infection of marrow cells with 
FLV-P,  are  BFU-E  that  attain  maximal  size  4-5  d  after  infection  and  probably 
represent a cell midway between day 10 BFU-E and day 2 CFU-E (38). This leads us 
to suggest that the marked effects of FLV-P infection on AMS-induced cultures is a 
reflection of the  initial  number of target  cells  present.  Accepting that  there  is  no 
continuous generation of these target cells from the primitive BFU-E, the sustained 
erythropoiesis over many months indicates that at least some of these target cells are 
capable of self-renewal. In fact, this is supported by our data (Table III), which show 
that  8  wk after FLV-P infection, there were no detectable normal  progenitor cells 
(CFU-S or day 14 BFU-E) in the cultures, although large scale production oferythroid 
cells (some of them "spontaneously" hemoglobinizing) was still occurring. 
Therefore, at  least  two  components  have  so  far  been  recognized,  perhaps  not 
mutually  exclusive:  the  generation  of erythropoietin  independency,  and  the  self- 
renewal of target cells. 
Finally,  there  is  the  question  of autonomous  growth:  the  production of Friend 
tumor cell lines. Thus far, we have been unable to produce permanently growing cell 
lines by subculturing cells directly from the primary, FLV-P-infected cultures. This 
is somewhat surprising in view of the finding that 8 wk after FLV-P infection, the 
primary cultured cells will  readily grow in soft-gel media in  the absence of added 
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liquid media, no sustained growth was seen. However, when the cells were reseeded 
onto a  fresh  marrow-adherent  layer, extensive proliferation was  seen  and  autono- 
mously growing cell lines could routinely be established from such secondary cultures. 
These lines are erythroid in character, are aneuploid and are (so far) not inducible 
with dimethyl sulfoxide (19). These data are reminiscent of the description of Friend 
disease in vivo. The early stages of the disease are notoriously difficult to transplant 
(6, 22), and cell lines are difficult to produce in vitro. In fact, the majority of Friend 
tumor cell lines in vitro have been produced from subcutaneously transplanted Friend 
tumor cells (18,  39), i.e., passage in vivo somehow enhances the capacity of cells to 
grow independently of host environmental influences and be propagated as in vitro 
cell  lines.  That  the  host  environment  is  indeed  important  in  the  development of 
Friend tumor cells is indicated by a  recent study (23)  that only in the late stages of 
Friend disease  (10 wk after infection) were the cells able to colonize the spleens of 
environmentally defective Steel (Sl/Sl d) mice, i.e., to proliferate independently of the 
environment. Also, studies using F-MuLV have demonstrated that only the late stages 
of the leukemia are transplantable and that from these secondary recipients, perma- 
nently growing cell lines can be established. 2 This initial host dependency of devel- 
oping leukemic cells is not unique to the Friend-associated viruses. Leukemias induced 
by chemicals  (40)or by certain strains of Rad-LV  (radiation-induced viruses)  (41) 
also  demonstrate  the  intimate  interactions  between  the  host  and  the  developing 
leukemic cell. 
Our  finding that  permanently growing cell lines can only be established  after a 
further passage of the cells onto a  marrow environment (the adherent layer) seems 
analogous with transplantation of tumor cells in vivo, and represents a third compo- 
nent of the Friend disease in vitro. The lack of dimethyl sulfoxide inducibility of these 
cells allows them to be tentatively placed in the stage III category of Friend leukemic 
cells discussed by Levy et al.  (39).  In this scheme, a  later stage of in vitro transfor- 
mation,  manifested  by  dimethyl  sulfoxide  inducibility  (stage  IV),  is  described.  It 
remains to be seen whether our cell lines will undergo this further progression. 
In conclusion, we have shown that  in appropriate conditions Friend disease can 
now be reproduced in vitro. This system allows sequential analysis of events occurring 
at all developmental levels of the hemopoietic system; and by using the wide variety 
of clonogeneic and molecular biological techniques now available, the system should 
be  very  useful  for  studying  events  occurring  in  so-called  tumor  progression  to 
malignancy. At the present, we are investigating the role of the helper-independent 
and  replication-defective transforming  viruses  (the  anemia  and  the  polycythemia 
strains)  in  the  generation  of the  different  stages  of Friend  disease  in  vitro  and 
examining the importance of the Fv-2 gene locus (42) in marrow chimeras in vitro. 
Summary 
In long-term marrow cultures, hemopoiesis can be maintained for several months, 
although erythropoiesis is normally suppressed at the most primitive level of devel- 
opment  (the erythroid colony-forming cells). Infection of these cultures with a  viral 
complex  combining  helper-independent  murine  leukemia  virus  (F-MuLV)  and  a 
z Oliff, A., S. Ruscetti, E. C. Douglass, and E. Scolnick.  Isolation of transplantable erythroleukemia cells 
from  mice infected with helper-independent Friend murine leukemia virus.  Manuscript submitted for 
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spleen  focus-forming virus  (SFFVp)  results  in  a  productive  infection  of both  the 
replication  defective SFFVp and  the F-MuLV. After infection, the cultures show a 
dramatic elevation in the numbers of late erythroid progenitor cells  (CFU-E), many 
of which will grow in the absence of added erythropoietin, and a  transient  erythro- 
poietin, independent erythropoiesis, including the production of mature, enucleated 
erythrocytes. Hemopoiesis eventually declines, with no evidence for the generation of 
Friend  tumor  cells.  When  erythropoiesis  is  induced  in  the  long-term  cultures  by 
addition of anemic mouse serum before infection by polycythemia-inducing Friend 
virus, the generation oferythropoietin-independent CFU-E and erythrocyte formation 
is followed by the sustained production (>40 wk) of primitive erythroid cells with low 
spontaneous  levels  (<5%)  of hemoglobinization.  Although these  cells  will  produce 
spleen colonies in  irradiated  mice and can be cloned in soft-gel media,  they do not 
produce  autonomous,  permanently  growing  cell  lines  in  vitro,  i.e.,  they  retain  a 
dependency upon the marrow-adherent layer for their continued growth. However, 
following a  further passage on a  "virgin" marrow environment, permanent cell lines 
can be established that are able to grow independently of environmental influences. 
Thus,  this  system  is  the  first  description  of a  complete  in  vitro  system  for  the 
reproducible production and isolation of Friend virus-induced erythroid cell lines. 
We would like to thank Dr. David Scott for allowing us to publish the karyotype data and Ms. 
J. Trent and Mr. G. R. Bennion for excellent technical  assistance. 
Received for publication  4 May 1981. 
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